ImmuCell Corp. (ICCC)
9.84
-0.06
(-0.61%)
USD |
NASDAQ |
Sep 08, 16:00
9.97
+0.13
(+1.32%)
After-Hours: 20:00
ImmuCell 1 Year Total Returns (Daily) : 50.11% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 50.11% |
| September 04, 2026 | 51.84% |
| September 03, 2026 | 53.23% |
| September 02, 2026 | 61.81% |
| September 01, 2026 | 55.00% |
| August 31, 2026 | 52.97% |
| August 28, 2026 | 62.42% |
| August 27, 2026 | 64.26% |
| August 26, 2026 | 60.32% |
| August 25, 2026 | 61.71% |
| August 24, 2026 | 61.50% |
| August 21, 2026 | 68.23% |
| August 20, 2026 | 66.98% |
| August 19, 2026 | 71.69% |
| August 18, 2026 | 59.74% |
| August 17, 2026 | 58.94% |
| August 14, 2026 | 49.55% |
| August 13, 2026 | 66.92% |
| August 12, 2026 | 65.11% |
| August 11, 2026 | 64.41% |
| August 10, 2026 | 64.71% |
| August 07, 2026 | 79.15% |
| August 06, 2026 | 78.32% |
| August 05, 2026 | 73.81% |
| August 04, 2026 | 77.26% |
| Date | Value |
|---|---|
| August 03, 2026 | 84.00% |
| July 31, 2026 | 75.98% |
| July 30, 2026 | 71.21% |
| July 29, 2026 | 69.65% |
| July 28, 2026 | 69.53% |
| July 27, 2026 | 68.38% |
| July 24, 2026 | 63.17% |
| July 23, 2026 | 57.27% |
| July 22, 2026 | 62.96% |
| July 21, 2026 | 64.27% |
| July 20, 2026 | 68.43% |
| July 17, 2026 | 68.56% |
| July 16, 2026 | 72.29% |
| July 15, 2026 | 71.41% |
| July 14, 2026 | 80.31% |
| July 13, 2026 | 70.99% |
| July 10, 2026 | 67.02% |
| July 09, 2026 | 69.70% |
| July 08, 2026 | 60.33% |
| July 07, 2026 | 58.22% |
| July 06, 2026 | 57.31% |
| July 02, 2026 | 61.03% |
| July 01, 2026 | 66.16% |
| June 30, 2026 | 44.40% |
| June 29, 2026 | 46.81% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 8.63% |
| Alnylam Pharmaceuticals, Inc. | -42.84% |
| Anika Therapeutics, Inc. | 135.3% |
| Savara, Inc. | 43.64% |
| Vericel Corp. | 17.64% |